drugset / Trial / NCT05459402
Divided or Single Exposure (DOSE) Study
Phase 2/3
Recruiting
150 enrolled
University of Maryland, Baltimore
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.
Timeline
- Start
- 2023-02-21
- Primary completion
- 2027-06-01
- Completion
- 2028-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methadone | Other / unclassified | 50 % | — |
| Comparator | Methadone | Other / unclassified | 100 % | — |